Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Cigna Group (NYSE:CI)

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Cigna Group, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Current insurance and contractholder liabilities 3.46 3.47 3.61 3.78 3.61 4.91 5.02 4.84 3.74 4.23 3.70 3.72 3.43 3.84 3.79 3.78 3.41 3.26 3.17 3.25
Pharmacy and other service costs payable 18.26 18.27 17.69 15.86 12.97 12.91 12.41 11.90 11.86 11.56 10.77 9.98 9.88 9.53 9.38 9.05 8.59 7.83 7.43 6.98
Accounts payable 5.96 5.40 5.97 5.30 5.60 5.13 5.38 4.97 5.40 4.76 4.68 4.35 4.30 3.67 3.66 3.71 3.52 3.33 3.39 3.61
Accrued expenses and other liabilities 6.02 5.66 5.79 5.78 6.52 6.46 5.66 6.20 5.56 5.54 5.07 5.13 4.73 4.77 4.68 5.21 5.48 4.47 5.01 4.90
Short-term debt 1.95 1.63 1.10 1.12 1.82 2.04 3.08 2.31 2.08 2.42 1.57 1.42 1.64 1.75 0.99 0.27 2.17 4.03 2.98 2.81
Liabilities of businesses held for sale 1.55 1.76 1.45 2.10 1.38 0.00 0.00 0.00 0.00 0.00 3.83 4.01 4.15 0.00 0.00 0.00 0.00 4.50 4.45 4.55
Current liabilities 37.19% 36.20% 35.62% 33.95% 31.89% 31.45% 31.55% 30.23% 28.64% 28.51% 29.63% 28.61% 28.13% 23.56% 22.51% 22.01% 23.17% 27.42% 26.42% 26.10%
Non-current insurance and contractholder liabilities 6.58 6.71 6.72 6.95 7.14 7.54 7.71 7.97 7.98 8.08 7.72 7.97 8.11 10.75 10.81 10.80 10.84 10.13 10.06 10.24
Deferred tax liabilities, net 4.47 4.31 4.47 4.59 4.70 5.00 5.06 5.21 5.39 5.39 5.25 5.31 5.39 5.73 5.75 5.81 5.75 5.71 5.74 5.86
Other non-current liabilities 2.06 1.92 2.28 2.39 2.25 1.96 1.72 1.82 2.18 2.20 2.08 2.19 2.43 2.76 2.81 2.95 2.98 2.84 2.99 2.92
Long-term debt 18.56 19.18 19.41 20.28 18.43 18.77 18.74 19.68 19.52 19.48 20.30 20.32 20.10 20.49 20.50 20.76 19.01 18.46 19.91 20.78
Separate account liabilities 4.67 4.85 4.78 4.84 4.86 4.70 4.88 4.96 5.06 5.03 4.91 5.34 5.38 5.93 6.01 5.98 5.84 5.38 5.18 4.94
Liabilities of businesses held for sale, non-current 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-current liabilities 36.35% 36.97% 37.66% 39.05% 37.77% 37.97% 38.11% 39.64% 40.12% 40.19% 40.26% 41.14% 41.41% 45.66% 45.87% 46.29% 44.41% 42.53% 43.88% 44.74%
Total liabilities 73.54% 73.17% 73.29% 72.99% 69.66% 69.42% 69.66% 69.86% 68.77% 68.70% 69.88% 69.75% 69.54% 69.22% 68.38% 68.30% 67.59% 69.95% 70.30% 70.84%
Redeemable noncontrolling interests 0.00 0.00 0.00 0.00 0.07 0.04 0.04 0.05 0.05 0.03 0.03 0.04 0.03 0.04 0.03 0.04 0.04 0.04 0.02 0.02
Common stock, $0.01 par value per share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 20.07 19.78 19.97 19.78 20.08 20.42 20.28 20.50 21.01 20.38 19.61 19.48 19.09 18.85 19.07 19.24 18.64 17.98 17.98 18.46
Accumulated other comprehensive loss -1.50 -1.37 -1.57 -1.52 -1.22 -1.42 -1.25 -1.20 -0.97 -1.39 -1.36 -0.98 -0.57 -0.75 -0.70 -0.81 -0.55 -0.34 -0.49 -0.99
Retained earnings 27.92 26.95 27.10 26.76 27.27 27.39 26.61 26.25 26.31 25.69 22.69 21.90 21.04 20.62 19.79 19.32 18.38 15.27 14.44 13.77
Treasury stock, at cost -20.17 -18.66 -18.92 -18.14 -15.87 -15.86 -15.36 -15.48 -15.18 -13.45 -10.87 -10.21 -9.15 -7.98 -6.57 -6.09 -4.10 -2.90 -2.26 -2.10
Shareholders’ equity 26.32% 26.70% 26.59% 26.89% 30.26% 30.53% 30.29% 30.07% 31.18% 31.23% 30.07% 30.20% 30.42% 30.74% 31.59% 31.66% 32.37% 30.01% 29.67% 29.14%
Other noncontrolling interests 0.13 0.13 0.13 0.11 0.01 0.01 0.01 0.01 0.01 0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total equity 26.46% 26.83% 26.71% 27.01% 30.27% 30.54% 30.30% 30.08% 31.18% 31.26% 30.09% 30.21% 30.43% 30.75% 31.59% 31.66% 32.38% 30.02% 29.68% 29.14%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

The balance sheet structure exhibits a progressive shift in the composition of liabilities and equity from March 2020 through December 2024. The most prominent trend is a migration of the liability profile from non-current to current obligations, alongside a significant increase in share repurchase activity that has impacted the overall equity position.

Shift in Liability Composition
Current liabilities have trended upward, increasing from 26.10% in March 2020 to 37.19% by December 2024. Conversely, non-current liabilities declined from 44.74% to 36.35% over the same period. This shift indicates a growing relative weight of short-term obligations compared to long-term liabilities.
Analysis of Current Obligations
The rise in current liabilities is primarily driven by pharmacy and other service costs payable, which grew substantially from 6.98% to 18.26%. Other contributing factors include a moderate increase in accounts payable, rising from 3.61% to 5.96%, and accrued expenses, which increased from 4.90% to 6.02%.
Non-Current Liability Trends
A consistent decline is observed in non-current insurance and contractholder liabilities, which dropped from 10.24% to 6.58%. Long-term debt remained relatively stable for the majority of the period, fluctuating between 18% and 21%, before ending at 18.56% in December 2024.
Equity and Capital Management
Total equity showed a gradual decline from a peak of 32.38% in December 2020 to 26.46% by December 2024. This decline occurred despite a strong upward trend in retained earnings, which grew from 13.77% to 27.92%. The net reduction in equity is attributed to an aggressive increase in treasury stock acquisitions, which expanded from -2.10% to -20.17%, suggesting an intensive share buyback program.
Overall Leverage Position
Total liabilities remained relatively stable around the 68% to 70% range for several years but showed an upward trajectory starting in 2023, reaching 73.54% by the end of 2024. This indicates a moderate increase in the company's reliance on debt and obligations relative to its equity base.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?